Sonata Capital Group Inc Bristol Myers Squibb CO Transaction History

Sonata Capital Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 03, 2020	SELL	$54.82 - $64.09 $229,092 - $267,832	-4,179 Closed	0 $0
Q1 2020 Apr 27, 2020	SELL	$46.4 - $67.43 $9,280 - $13,486	-200 Reduced 4.57%	4,179 $233,000
Q4 2019 Jan 30, 2020	BUY	$49.21 - $64.19 $215,490 - $281,088	4,379 New	4,379 $281,000
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $213,462 - $236,042	-4,784 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$48.76 - $63.23 $12,238 - $15,870	-251 Reduced 4.99%	4,784 $249,000

Q3 2018 Oct 31, 2018	SELL	$55.19 - $62.25 $29,250 - $32,992	-530 Reduced 9.52%	5,035 $313,000
Q2 2018 Aug 01, 2018	BUY	$50.53 - $62.98 $26,780 - $33,379	530 Added 10.53%	5,565 $308,000
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $278,083 - $320,930	5,035	5,035 $321,000

2,553

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sonata Capital Group Inc, based on Form 13F filings with the SEC.

Stay updated on Sonata Capital Group Inc with notifications on news.